X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/14/2846676/0/en/Allakos-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/26/2835016/0/en/Allakos-Presents-Preclinical-Data-Highlighting-Inhibition-of-MRGPRX2-Mediated-Mast-Cell-Activation-with-AK006-at-AAAAI-2024.html
https://www.globenewswire.com//news-release/2024/02/12/2827417/0/en/Allakos-Announces-Publication-Highlighting-AK006-Mast-Cell-Inhibition.html
https://endpts.com/allakos-halves-workforce-drops-lead-inflammatory-program/
https://investor.allakos.com/news-releases/news-release-details/allakos-announces-phase-2-lirentelimab-trials-atopic-dermatitis
https://www.globenewswire.com//news-release/2023/11/13/2779419/0/en/Allakos-Provides-Business-Update-and-Reports-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2023/08/30/2734781/0/en/Allakos-Appoints-Neil-Graham-to-its-Board-of-Directors.html
https://www.globenewswire.com/news-release/2023/08/09/2722085/0/en/Allakos-Provides-Business-Update-and-Reports-Second-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/08/02/2717345/0/en/Allakos-Appoints-Rand-Sutherland-and-Dolca-Thomas-to-its-Board-of-Directors.html
https://www.globenewswire.com/news-release/2023/06/12/2686167/0/en/Allakos-Presents-Preclinical-Data-at-EAACI-Hybrid-Congress-2023-Highlighting-Lirentelimab-and-AK006-Mechanisms-of-Mast-Cell-Inhibition.html
Market Place
Share 
